News

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.
Brad Smith outlines the top stories on Wall Street as part of Yahoo Finance's Market Minute. Vertiv Holdings (VRT) stock is ...